• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides from the July 21-22, 2011 TPSAC Meeting - Dissolvables Session


FDA presentation: Dissolvable Tobacco Products

David L. Ashley, Ph.D., Director, Office of Science, FDA/CTP
      
FDA presentation: Process for the Report

Karen Templeton-Somers, Ph.D., Office of Science, FDA/CTP

Industry presentations:  Marketing and Consumer Perception

Star Scientific - Curtis Wright, M.D., M.P.H., Senior Vice President & Clinical Director, Rock Creek Pharmaceuticals

R. J. Reynolds Tobacco Company - Aaron P. Williams, Ph.D., Vice President, Smokeless Product Development, R. J. Reynolds

Industry presentations: Abuse Liability and Health Risks
 
R. J. Reynolds Tobacco Company - Charles D. Garner, Ph.D.  Senior Director, Regulatory Oversight, R. J. Reynolds
   
Star Scientific - Curtis Wright, M.D., M.P.H., Senior Vice President & Clinical Director, Rock Creek Pharmaceuticals

Industry presentations: Initiation and Cessation

Star Scientific - Curtis Wright, M.D., M.P.H.    Senior Vice President & Clinical Director, Rock Creek Pharmaceuticals

R. J. Reynolds Tobacco Company - Geoffrey M. Curtin, Ph.D., Principal Scientist/Director, Regulatory Oversight, R. J. Reynolds
 
 

FDA presentation: Dissolvable Tobacco Products

Sarah E. Evans, Ph.D., Office of Science, FDA/CTP

Open Public Hearing

 Elaine Keller  - The Consumer Advocates for Smoke-free Alternatives Association

 Wallace Pickworth  -  Battelle

 James E. Dillard, III  -  Altria Client Services

 Jonathan Winickoff, MD, FAAP  - American Academy of Pediatrics

 Gregory N. Connolly, D.M.D., M.P.H. - Harvard School of Public Health

Questions to the Committee

If you have problems accessing these PDF documents, please call 1-877-287-1373 for assistance.